Bio-Techne Corporation TECH

TECH Company Overview

Bio-Techne Corporation (NASDAQ: TECH) is a U.S.-based life sciences and diagnostics company that develops and manufactures biotechnology reagents, analytical instruments, and diagnostic products used in biological research, clinical diagnostics, and cell and gene therapy development. The company operates primarily within the biotechnology tools and diagnostics industries, serving pharmaceutical companies, biotechnology firms, academic institutions, hospitals, and clinical laboratories. Its core revenue drivers include protein analysis products, immunoassays, molecular diagnostics solutions, and cell therapy workflow tools. Bio-Techne is widely recognized for its portfolio of high-quality antibodies, proteins, assays, and genomic analysis technologies used in biomedical research and translational medicine.

The company traces its origins to 1976 and evolved through a combination of organic product development and strategic acquisitions. Bio-Techne expanded significantly through the integration of brands such as R&D Systems, ProteinSimple, ACD, and Exosome Diagnostics, which broadened its capabilities across proteomics, genomics, spatial biology, and precision diagnostics. The company has positioned itself as a supplier of specialized, high-value research and clinical tools with recurring demand characteristics and strong exposure to growth areas such as cell and gene therapy, spatial biology, and molecular diagnostics.